About the job
Join Veracyte, a trailblazing company dedicated to revolutionizing cancer care for patients globally. At Veracyte, our employees contribute significantly to patient outcomes while thriving in a mission-driven culture. We embody the Veracyte way, a collaborative approach rooted in our values to empower clinicians with crucial insights for transformative patient decisions.
Our Core Values:
- We Seek A Better Way: We boldly innovate, learn from our challenges, and remain resilient in transforming cancer care.
- We Make It Happen: We act swiftly, commit to excellence, and infuse joy into our work.
- We Are Stronger Together: We foster open collaboration, seek understanding, and celebrate successes.
- We Care Deeply: We honor our differences, uphold integrity, and support one another.
Position Overview:
As the Executive Director of Discovery, you will leverage your expertise as a forward-thinking scientific leader to propel Veracyte's innovative discovery initiatives. Your focus will be on identifying and developing groundbreaking biomarkers, technologies, and platforms that further our mission in transforming cancer care. You will integrate laboratory cancer biology, genomic methodologies, and cutting-edge bioinformatics, including multi-modal artificial intelligence (MMAI), to discover new molecular diagnostics poised for clinical application.
This pivotal role aligns with Veracyte's objective of delivering impactful genomic solutions to enhance patient outcomes globally. Having served hundreds of thousands of patients, we are committed to pioneering diagnostic innovations grounded in rigorous scientific research and advanced analytics.
The ideal candidate will possess extensive hands-on experience in cancer biology, genomic technologies, and computational analysis, along with a proven ability to translate complex biological signals into diagnostic product concepts. This position demands excellence in managing laboratory discovery programs, developing high-quality datasets, and guiding teams to produce robust, reproducible evidence suitable for subsequent development under stringent design controls.
